The Future of Nanomedicine in Veterinary Science

Authors

  • Prince Pandey Student, Department of Biotech, Noida institute of Engineering and Technology, Greater Noida, Uttar Pradesh, India

Keywords:

Nanomedicine, nanoformulations, veterinary science, therapeutics, diseases

Abstract

Nanomedicine is a new and emerging field that will not only change the way veterinary medicine is practiced but will also enhance present medications and sickness detection. Nanomedicine has been linked to target-specific medication delivery using nanoparticle formulations such as liposomes, SLNs, and fullerenes. It is the use of nanotechnology to develop quicker and more effective disease management solutions by working on a nanoscale and producing target-oriented effects. Certain nanoparticles are also being eyed as a possible adjuvant, with the potential to improve antigen presentation efficacy and extend immunization durability. As a result, this research work will give a glimpse of the likely future of nanomedicine in veterinary research and keep veterinarians up to date on the new technology.

References

Mohantya N, et al. An overview of nanomedicine in veterinary science. Vet Res. 2014; 2(4): 90–5.

Feneque J. Nanotechnology: a new challenge for veterinary medicine. The Pet Tribune. 2000; 6(5):16.

Feneque J. (2003). Brief introduction to the veterinary applications of anotechnology. [Online].Nanotechnology Now.

Baker James R, et al. The synthesis and testing of anti-cancer therapeutic nanodevices. Biomed Microdevices. 2001; 3(1): 61–69.

Bakker-Woudenberg Irma AJM, et al. Long-circulating sterically stabilized liposomes in the treatment of infections. Methods in enzymology. Vol. 391. Academic Press; 2005; 228–260.

Jain Kewal K. Nanotechnology in clinical laboratory diagnostics. Clin Chim Acta. 2005; 358(1–2): 37–54.

Underwood Claire, Van Eps AW. Nanomedicine and veterinary science: The reality and the practicality. Vet J. 2012; 193(1): 12–23.

Kim Betty YS, Rutka James T, Chan Warren CW. Nanomedicine. N Engl J Med. 2010; 363(25): 2434–2443.

Koo Otilia M, Israel Rubinstein, Hayat Onyuksel. Role of nanotechnology in targeted drug delivery

and imaging: a concise review. Nanomed: Nanotechnol Biol Med. 2005; 1(3): 193–212.

Kroubi Maya, et al. Development of a nanoparticulate formulation of diminazene to treat African trypanosomiasis. Nanotechnology. 2010; 21(50): 505102.

Scott NR. Nanoscience in veterinary medicine. Vet Res Commun. 2007; 31(1): 139–144.

Rapoport Natalya, et al. Ultrasonic nanotherapy of pancreatic cancer: lessons from ultrasound imaging. Mol Pharm. 2010; 7(1): 22–31.

Mishra BBTS, Patel Bhavesh B, Sanjay Tiwari. Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. Nanomed: Nanotechnol Biol Med. 2010; 6(1): 9–24.

Downloads

Published

2022-05-23

Issue

Vol. 11 No. 1 (2022)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.